Home » BioWorld Stock Report For Public Biotechnology Companies

BioWorld Stock Report For Public Biotechnology Companies

Jan. 10, 2005

To read more on related topics, click on one of the words below.

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for June 4, 2025.
Regeneron boosts obesity pipeline with Hansoh’s GLP-1/GIP for $2B
BioWorld
Regeneron Pharmaceuticals Inc. is adding to its obesity pipeline by in-licensing Hansoh Biomedical Co. Ltd.’s phase III dual glucagon-like peptide 1...
Pharma execs speak out: UK pricing rebates scare investors
BioWorld
The row between pharma companies and the U.K. government over rebates has intensified, with the Association of the British Pharmaceutical Industry calling up its...
ASCO 2025: Verastem has positive cancer data but stock sags
BioWorld
New dose-escalation data from Verastem Oncology’s phase I/II cancer study in China prompted the company to say it was encouraged by the efficacy results. However,...